Log in to save to my catalogue

Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 a...

Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2041628175

Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients

About this item

Full title

Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients

Publisher

Cham: Springer Science and Business Media LLC

Journal title

Aging Clinical and Experimental Research, 2018-12, Vol.30 (12), p.1459-1464

Language

English

Formats

Publication information

Publisher

Cham: Springer Science and Business Media LLC

More information

Scope and Contents

Contents

Aim
Procalcitonin (PCT) has predictive value for patients with infectious diseases, but has not been studied in frailty. The purpose of this study was to compare PCT to two other inflammatory biomarkers [interleukin-6 (IL-6)] and C-reactive protein (CRP) in their association with frailty among older hospitalized patients.
Methods
Retrospec...

Alternative Titles

Full title

Comparison of procalcitonin, a potentially new inflammatory biomarker of frailty, to interleukin-6 and C-reactive protein among older Chinese hospitalized patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2041628175

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2041628175

Other Identifiers

ISSN

1720-8319,1594-0667

E-ISSN

1720-8319

DOI

10.1007/s40520-018-0964-3

How to access this item